Here are five observations:
1. The shift to outpatient spine surgery serves as the ultimate boost for the spinal implants market.
2. The increasing number of non-fusion spinal procedures will also spur market growth.
3. With the growing popularity of non-fusion procedures, many companies have started developing devices for artificial disc replacement, dynamic stabilization and interspinous process decompression.
4. Spinal implant-associated complications could hinder market growth.
5. DePuy Synthes, Medtronic, NuVasive, Stryker and Zimmer Biomet lead the market.
More articles on devices:
St. Mary’s Medical Center surgeons complete 100th Mazor robotic spine surgery: 3 highlights
Avitus Orthopaedics launches Avitus Bone Harvester — 5 highlights
Top 5 vendors in global sports medicine market: Stryker, DePuy Synthes & more
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
